Rockwell Medical (RMTI) Total Current Liabilities (2010 - 2026)
Rockwell Medical (RMTI) posted Total Current Liabilities of $9.9 million for Q1 2026, up 3.01% on a QoQ basis from $9.6 million in Q4 2025, and down 11.93% year-over-year from $11.2 million in Q1 2025.
Rockwell Medical (RMTI) Total Current Liabilities (2010 - 2026) Analysis & Trends
Rockwell Medical's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $9.9 million for Q1 2026.
- Quarterly Total Current Liabilities fell 11.93% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.9 million (down 11.93% YoY) and the FY2025 annual result came in at $9.6 million, down 32.01% from the prior year.
- Total Current Liabilities was $9.9 million for Q1 2026 at Rockwell Medical, up from $9.6 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $21.4 million in Q3 2023 and bottomed at $9.6 million in Q4 2025.
- A 5-year average of $15.0 million and a median of $14.9 million in 2024 frame the typical range for Total Current Liabilities.
- Peak annual rise in Total Current Liabilities reached 74.46% in 2022, while the deepest fall reached 45.55% in 2022.
- Rockwell Medical's Total Current Liabilities stood at $17.7 million in 2022, then decreased by 5.96% to $16.6 million in 2023, then retreated by 15.3% to $14.1 million in 2024, then sank by 32.01% to $9.6 million in 2025, then climbed by 3.01% to $9.9 million in 2026.
- Business Quant data shows RMTI's Total Current Liabilities at $9.9 million in Q1 2026, $9.6 million in Q4 2025, and $9.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 9.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.87 Mn |
| Dec 31, 2025 | 9.58 Mn |
| Sep 30, 2025 | 9.58 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 11.21 Mn |
| Dec 31, 2024 | 14.09 Mn |
| Sep 30, 2024 | 14.18 Mn |
| Jun 30, 2024 | 14.89 Mn |
| Mar 31, 2024 | 14.95 Mn |
| Dec 31, 2023 | 16.64 Mn |
| Sep 30, 2023 | 21.41 Mn |
| Jun 30, 2023 | 17.45 Mn |
| Mar 31, 2023 | 15.07 Mn |
| Dec 31, 2022 | 17.69 Mn |
| Sep 30, 2022 | 19.34 Mn |
| Jun 30, 2022 | 18.54 Mn |
| Mar 31, 2022 | 19.60 Mn |
| Dec 31, 2021 | 20.97 Mn |
| Sep 30, 2021 | 21.76 Mn |
| Jun 30, 2021 | 34.04 Mn |